Concepedia

Simon Weekx

SW

4

Publications

322

Citations

4

H-Index

1996

Active since

Affiliations

University of Antwerp(Current)

Simon Weekx is an author at University of Antwerp specializing in autoimmune disease, tumor microenvironment, and autoimmunity.

ORCID

Top concepts

Publications per year

1996–2021

4

Publications

4

COVID-19 and retail: The catalyst for e-commerce in Belgium?

Joris Beckers, Simon Weekx, Philippe Beutels et al. · Journal of Retailing and Consumer Services · 2021 · 169 citations · Full text

, , +9

CD34++ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source.

Simon Weekx, Dirk R. Van Bockstaele, Jean Plum et al. · PubMed · 1998 · 59 citations

Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma.

Hans‐Willem Snoeck, Simon Weekx, Adriaan C. Moulijn et al. · The Journal of Experimental Medicine · 1996 · 55 citations · Full text

, , +18

TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors.

P. C. F. Van Ranst, H.-W. Snoeck, Filip Lardon et al. · PubMed · 1996 · 39 citations

Rows per page

1–4 of 4